Global Dry Eye Products Market 2024 Emerging Trends, Industry Growth, Segmentation And Key Players Analysis Till 2033

The dry eye products market size has grown strongly in recent years. It will grow from $7.26 billion in 2023 to $7.74 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to aging population, environmental factors, consumer awareness, healthcare professional recommendations, ocular surgery proliferation.

The dry eye products market size is expected to see strong growth in the next few years. It will grow to $9.7 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to continued digital device usage, increased screen time, rising awareness and diagnosis, ophthalmic innovation, telemedicine and remote consultations. Major trends in the forecast period include advanced treatment modalities, preservative-free formulations, smart eye care devices, integration with wearable tech, combined therapy approaches.

Market Overview -
Dry eye products refer to products that provide relief and alleviate the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears, or the tears evaporate too quickly. These products lubricate the eyes, reduce inflammation, and increase moisture to relieve dryness, irritation, and discomfort.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12242&type=smp

Rising Prevalence Of Dry Eye Conditions Boosts Growth In Dry Eye Products Market
The rising prevalence of dry eye conditions is expected to propel the growth of the dry eye products market going forward. A dry eye is characterized by insufficient lubrication and moisture on the eye's surface. A dry eye can cause discomfort, irritation, and vision problems. Dry eye products help manage the symptoms of dry eye conditions. For instance, in March 2022, according to a survey conducted by Eyes on Eyecare with 540 eyecare experts, a US-based eyecare professionals' company, 35 million Americans will suffer from dry eye disease (DED) in 2022, with the frequency increasing year after year. Furthermore, according to UpToDate Inc., a US-based health information provider, in 2022 meta-analysis of three US studies showed an 8.1% pooled prevalence of dry eye. Therefore, the rising prevalence of dry eye conditions drives the growth of the dry eye products market.

Competitive Landscape -
Major companies operating in the dry eye products market report are Johnson & Johnson, AbbVie Inc., Novartis AG, Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Alcon Inc., Bausch Health Companies Inc, Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Lumenis, AFT Pharmaceuticals Limited, Biotrue Inc., URSAPHARM Arzneimittel GmbH, Sight Sciences, OCuSOFT Inc, Oasis Medical Inc., Novaliq GmbH, Similasan, MiBo Medical Group, TheraTears, Allergan Plc, Systane, Refresh Plus, Optase, Visine inc.

Technological Advancements In The Dry Eye Products Market
Technological advancements are a key trend gaining popularity in the dry eye products market. Major companies operating in the dry eye products market are adopting new technologies to sustain their position in the market. For instance, in January 2022, Sun Pharma Canada Inc., a Canada-based pharmaceutical company, launched CEQUA, a novel dry eye disease treatment catering to the needs of Canadian individuals experiencing this condition. CEQUA, containing cyclosporine ophthalmic solution 0.09% w/v, is distinguished as Canada's first dry eye treatment utilizing nano micellar (NCELL) technology. This advanced technology enhances the bioavailability and stability of cyclosporine, facilitating better penetration into ocular tissues for improved therapeutic outcomes.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/dry-eye-products-global-market-report

Key Segments -
The dry eye products market covered in this report is segmented -
1) By Product: Antibiotic Drops, Hormone Drops, Artificial Tears, Other Products
2) By Type: Prescription Drugs, Over-The-Counter Drugs
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, E-Commerce, Other Distribution Channel

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.